Global /Australia /Healthcare /Medical Devices /OSX

Osteopore Ltd.

OSX

• ASX: OSX • Delayed

0.0070AUD 17%

0.0050 USD

As of 5 June 2026, Osteopore Ltd. has a market cap of $2.41M USD, ranking #46754 globally and #1734 in Australia. It ranks #4138 in the Healthcare sector, and #868 in the Medical Devices industry.

Global Rank

46754

Country Rank

1734

Sector Rank

4138

Industry Rank

868

Key Stats

Market Cap

$2.41MUSD

3.38M AUD

Enterprise Value

$2.05MUSD

2.87M AUD

Revenue (TTM)

$2.18MUSD

3.06M AUD

EBITDA (TTM)

-$2.04MUSD

-2.85M AUD

Net Income (TTM)

-$2.66MUSD

-3.72M AUD

EBITDA Margin

-93%

Profit Margin

-122%

PS Ratio

1.1

PB Ratio

-2.0

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

Yujing Lim open_in_new

Founded

2003

Website

osteopore.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
17%	0%	-14%	-60%	-45%	-7.7%	-60%	-100%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	OSX Osteopore Ltd Ordinary Shares ISIN: AU0000053324 Shares Out.: Shares Outstanding: 626.358M¹ Shares Float: 572.797M² TV: TradingView: ASX: OSX SA: Stock Analysis: ASX: OSX YF: Yahoo Finance: OSX.AX GF: Google Finance: ASX: OSX BA: Barron's: OSX MS: Morningstar: XASX: OSX	0.0070 AUD	TV: TradingView: ASX: OSX SA: Stock Analysis: ASX: OSX YF: Yahoo Finance: OSX.AX GF: Google Finance: ASX: OSX BA: Barron's: OSX MS: Morningstar: XASX: OSX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Osteopore Ltd.

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical implants; sells medical devices; provides technology services; and engages in research and development activities. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 174K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 106K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 33K%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 31K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 7K%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 7K%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 7M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 7M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 7M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 5M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 5M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 4M%	22.2	Ireland

chevron_leftBack